Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a

被引：52
|
作者：
Anadolu, R [1 ]
Oskay, T [1 ]
Erdem, C [1 ]
Boyvat, A [1 ]
Terzi, E [1 ]
Gürgey, E [1 ]
机构：
[1] Ankara Univ, Fac Med, Dept Dermatol, TR-06100 Ankara, Turkey
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2001年 / 45卷 / 02期
关键词：
D O I：
10.1067/mjd.2001.114575
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Epidermodysplasia verruciformis (EV) is an autosomal recessive disease characterized by the lifelong eruption of disseminated verrucae-like lesions. Numerous treatment modalities have been used to treat EV without benefit. Recently, retinoid and interferon therapies have been found to be of value in the treatment of EV We present a case of EV that was treated with a combination of acitretin and interferon alfa-2a.
引用
收藏
页码：296 / 299
页数：4
相关论文
共 50 条
  • [21] REGRESSION OF A VENOUS MALFORMATION DURING TREATMENT WITH INTERFERON ALFA-2A
    HORD, D
    GREER, JP
    BLOOD, 1994, 84 (10) : A677 - A677
  • [22] TREATMENT OF MULTIPLE-MYELOMA WITH RECOMBINANT INTERFERON ALFA-2A
    OHNO, R
    KIMURA, K
    CANCER, 1986, 57 (08) : 1685 - 1688
  • [23] Interferon alfa-2a for melanoma metastases
    Kirkwood, JM
    Ibrahim, JG
    Sondak, VK
    Ernstoff, MS
    Ross, M
    LANCET, 2002, 359 (9310): : 978 - 979
  • [24] LYMPHOMATOID PAPULOSIS - TREATMENT WITH RECOMBINANT INTERFERON ALFA-2A AND ETRETINATE
    WYSS, M
    DUMMER, R
    DOMMANN, SN
    JOLLERJEMELKA, HI
    DOURSZIMMERMANN, MT
    GILLIET, F
    BURG, G
    DERMATOLOGY, 1995, 190 (04) : 288 - 291
  • [25] RESPONSE OF WARTS IN EPIDERMODYSPLASIA VERRUCIFORMIS TO TREATMENT WITH SYSTEMIC AND INTRALESIONAL ALPHA INTERFERON
    ANDROPHY, EJ
    DVORETZKY, I
    MALUISH, AE
    WALLACE, HJ
    LOWY, DR
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (02) : 197 - 202
  • [26] Surgical Treatment of Epidermodysplasia Verruciformis
    Hoffner, Mariana V.
    Camacho, Francisco M.
    DERMATOLOGIC SURGERY, 2010, 36 (03) : 363 - 367
  • [27] Bulevirtide in combination with pegylated interferon alfa-2a shows a sustained off-treatment response in the liver
    Allweiss, Lena
    Volmari, Annika
    Manuilov, Dmitry
    Urban, Stephan
    Wedemeyer, Heiner
    Nieves, Wildaliz
    Wallin, Jeffrey
    Mercier, Renee-Claude
    Lau, Audrey H.
    Dandri, Maura
    JOURNAL OF HEPATOLOGY, 2024, 80 : S74 - S75
  • [28] TREATMENT OF CUTANEOUS T-CELL LYMPHOMAS WITH INTERFERON ALFA-2A
    UNAL, A
    KARAOGLU, S
    SOYUER, U
    KONTAS, O
    ASCIOGLU, O
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1124 - 1124
  • [29] INTERFERON ALFA-2A IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA
    OLSEN, EA
    DIAB, NG
    CLINICAL RESEARCH, 1986, 34 (02): : A772 - A772
  • [30] Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy
    Barlow, CF
    Priebe, CJ
    Mulliken, JB
    Barnes, PD
    Mac Donald, D
    Folkman, J
    Ezekowitz, RAB
    JOURNAL OF PEDIATRICS, 1998, 132 (03): : 527 - 530
12345